ISRG vs Peers Stock Comparison

Intuitive Surgical Prices as of Oct 26, 2026 Peers: Industry group
ISRG Intuitive Surgical Inc
$451.63 +11.5% 1M -17.4% 1Y
Market cap
$155.58B
P/E
52.6x
Revenue (TTM)
$11.58B
Div. yield
–
Medical Devices Healthcare

Percentile Scorecard

ISRG

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisISRG
Valuation 53 #108 of 228
Growth 80 #45 of 221
Profitability 98 #6 of 208
Financial Health 78 #53 of 239
Shareholder Returns 92 #12 of 137
Overall 80
  • ISRG ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodISRGSPY
1 month +11.5% -0.8%
3 months +26.6% +3.5%
6 months -4.1% +7.0%
Year to date -20.3% +12.2%
1 year -17.4% +13.0%
3 years +74.4% +86.3%
3 years, per year +20.4% +23.1%
5 years +29.4% +68.6%
5 years, per year +5.3% +11.0%
10 years +510.6% +258.0%
10 years, per year +19.8% +13.6%

Risk

MeasureISRGSPY
Volatility, 1Y 34.6% 12.7%
Downside volatility, 1Y 37.5% 12.7%
Beta vs S&P 500, 1Y 0.90 1.00
Return / volatility, 1Y -0.50 1.02
Max drawdown, 5Y -49.9% -25.4%
From 52-week high -23.8% -1.8%
52-week high $592.85 $779.14
52-week low $332.02 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleISRG
P/E now vs peer median 53.3xmedian 30.6x
P/S now vs peer median 13.5xmedian 3.0x
EV/EBITDA now vs peer median 37.3xmedian 17.5x
P/FCF now vs peer median 43.5xmedian 23.3x
P/B now vs peer median 9.7xmedian 2.4x
PEG now vs peer median 2.07median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsISRG
Revenue $11.58B
Gross profit $7.78B
Operating income $3.28B
Net income $2.97B
Free cash flow $3.60B
R&D $1.49B
EPS (diluted) $8.41
Cash & equivalents $2.98B
Shares (diluted) 351.60M
Enterprise value $135.87B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricISRG
P/E 53.3x
P/FCF 43.5x
P/Operating cash flow 38.3x
P/S 13.5x
P/B 9.7x
P/Tangible book 10.5x
EV/EBITDA 37.3x
EV/EBIT 46.4x
EV/Revenue 13.2x
EV/FCF 42.4x
EV/Operating cash flow 37.3x
PEG (3Y EPS CAGR) 2.07

Growth

14 metrics
MetricISRG
Revenue growth (1Y) 20.5%
Revenue CAGR (3Y) 19.1%
Gross profit growth (1Y) 21.9%
Gross profit CAGR (3Y) 19.5%
Operating income growth (1Y) 16.6%
Operating income CAGR (3Y) 24.8%
Net income growth (1Y) 7.5%
Net income CAGR (3Y) 24.4%
EPS growth (1Y) 10.8%
EPS CAGR (3Y) 25.7%
Operating cash flow growth (1Y) 38.1%
Operating cash flow CAGR (3Y) 26.4%
Free cash flow growth (1Y) 58.4%
Free cash flow CAGR (3Y) 42.0%

Profitability

14 metrics
MetricISRG
Gross margin 67.2%
EBITDA margin 35.3%
Operating margin 28.4%
Pretax margin 31.3%
Net margin 25.5%
FCF margin 31.1%
Operating cash flow margin 35.3%
Return on equity 17.3%
Return on assets 14.8%
Return on invested capital –
Return on capital employed 18.7%
Asset turnover 0.6x
Cash conversion (OCF / net income) 1.4x
Stock comp / revenue 7.2%

Financial Health

11 metrics
MetricISRG
Debt / assets –
Debt / equity –
Net debt / EBITDA –
Debt / FCF –
Liabilities / assets 16.7%
Equity / assets 83.3%
Interest coverage –
Current ratio 3.3x
Quick ratio 2.3x
Cash ratio 1.6x
Altman Z-score 30.92

Shareholder Returns

7 metrics
MetricISRG
Dividend yield –
Net buyback yield 2.7%
Shareholder yield 2.7%
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusISRG
Forward P/E 39.4xFY2026
EPS, next fiscal year $11.47FY2026
EPS growth, next FY +28.4%FY2026
EPS growth, the year after +4.5%
Revenue, next fiscal year $11.60BFY2026
Revenue growth, next FY +15.3%FY2026
Revenue growth, the year after +11.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersISRG
Held by institutions 86.2%
Institutions holding 2,235
Change in shares held, QoQ +4.6%
Institutions buying 1,070
Institutions selling 877
Buyers to sellers 1.22

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.